EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter

Nitesh Kumar Khandelwal, Meghna Gupta iD, Paras Kumar, Sree Ganesh Balasubramani, Ignacia Echeverria iD, Robert M Stroud iD

Proceedings of the National Academy of Sciences · 18.02.2025 · 122 (7)

DOI: 10.1073/pnas.2418282122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.02.2025. Verfasst von Nitesh Kumar Khandelwal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94143. Hauptthemen laut MEDLINE: Uric Acid, Glucose Transport Proteins, Facilitative, Mutation, Hyperuricemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS), NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urate provides ~50% of the reducing potential in human and primate plasma which is key to detoxifying reactive oxygen by-products of cellular metabolism. Urate is the endpoint of purine metabolism in primates, and its concentration in plasma is a balance between excretion from kidney and intestine, and subsequent reabsorption in and through cells of kidney proximal tubules to maintain a regulated concentration in plasma. SLC2A9 is the primary transporter that returns urate from the basolateral side of kidney tubule cells back to plasma. A shorter splice variant of SLC2A9 is directed to the apical surface where several transporters recapture urate from the tubule back into cells. Too high a concentration in plasma causes hyperuricemia, is linked to gout, and favors kidney stone formation. To understand the molecular basis of uric acid transport and the role of disease-causing mutations in SLC2A9, we determined structures of human SLC2A9 in its apo form, and its urate-bound form by cryo-EM, at resolution of 3.3 Å and 4.1 Å respectively. Both structures are captured in an inward open conformation. Using the inward-facing structure as a template we modeled the outward-facing conformation to understand the alternating access mechanism. Alternative salt bridge pairs on the cytoplasmic side suggest a mechanism that can balance the energetics of the inward open and outward open states. The location of disease-causing mutants suggests their role in impacting function. Our structures elucidate the molecular basis for urate selectivity and transport and provide a platform for future structure-based drug discovery aimed at reducing plasma urate levels in diseases of hyperuricemia and gout.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uric AcidGlucose Transport Proteins, FacilitativeMutationHyperuricemiaHumansCryoelectron MicroscopyGoutModels, Molecular

Stichwörter der Autor:innen

SLC2A9cryo-EMstructuretransporterurate

Substanzen

Uric AcidSLC2A9 protein, humanGlucose Transport Proteins, Facilitative

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94143.
  • Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158.
  • Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158.

ORCID-Profile: Meghna Gupta, Ignacia Echeverria, Robert M Stroud

Förderung

  • NIGMS NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • NIH HHS

Zitieren

APA

Khandelwal, N. K., Gupta, M., Kumar, P., Balasubramani, S. G., Echeverria, I., & Stroud, R. M. (2025). Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter. Proceedings of the National Academy of Sciences, 122(7). https://doi.org/10.1073/pnas.2418282122

Vancouver

Khandelwal NK, Gupta M, Kumar P, Balasubramani SG, Echeverria I, Stroud RM. Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter. Proceedings of the National Academy of Sciences. 2025;122(7). doi:10.1073/pnas.2418282122

BibTeX
@article{Khandelwal2025,
  author = {Khandelwal, Nitesh Kumar and Gupta, Meghna and Kumar, Paras and Balasubramani, Sree Ganesh and Echeverria, Ignacia and Stroud, Robert M},
  title = {Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {7},
  doi = {10.1073/pnas.2418282122}
}
Kostenlos starten →